Cardiology National Lipid Association (NLA) 2016 Scientific Sessions May 19-22, 2016 — New Orleans, Louisiana Efficacy and Safety of PCSK9 Inhibitors Now Measured In Years with No Change in Scale of Clinical Benefit Download 2 PowerPoint slides